McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia on Friday.
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its opioid painkiller OxyContin, a court filing said Friday.
The powerful consulting firm McKinsey will "accept responsibility" and pay $650 million for helping to fuel the opioid crisis, but executives will once again dodge prosecution.
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm's work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales.
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work...
McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales.
McKinsey & Company to pay $650M to resolve federal probe into opioids work | Since Then